S. Spector

449 total citations
11 papers, 330 citations indexed

About

S. Spector is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Spector has authored 11 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Spector's work include Esophageal Cancer Research and Treatment (3 papers), Virus-based gene therapy research (2 papers) and Cancer Research and Treatments (2 papers). S. Spector is often cited by papers focused on Esophageal Cancer Research and Treatment (3 papers), Virus-based gene therapy research (2 papers) and Cancer Research and Treatments (2 papers). S. Spector collaborates with scholars based in United States and Netherlands. S. Spector's co-authors include Lynn G. Feun, Niramol Savaraj, Medhi Wangpaichitr, C. Wu, Min You, M. Tien Kuo, Seth A. Spector, Joshua S. Jue, Chunjing Wu and George Theodoropoulos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

S. Spector

10 papers receiving 321 citations

Peers

S. Spector

MB

BIOTE

CR

GENET

ONCOL

Amalia E DeGortari United States

Wai Kin Chan United States

Choon-Taek Lee South Korea

Gongjian Zhu China

Joanna Mucha Poland

Sun Young South Korea

Liqin Ren China

Hongying Zheng China

Miranda McEwan New Zealand

Xiangming Yan China

Amalia E DeGortari United States

S. Spector

74 ×0.6

MB

44 ×0.4

BIOTE

31 ×0.3

CR

132 ×2.6

GENET

49 ×1.0

ONCOL

Citations per year, relative to S. Spector S. Spector (= 1×) peers Amalia E DeGortari

Countries citing papers authored by S. Spector

Since Specialization

Citations

This map shows the geographic impact of S. Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Spector more than expected).

Fields of papers citing papers by S. Spector

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Spector. The network helps show where S. Spector may publish in the future.

Co-authorship network of co-authors of S. Spector

This figure shows the co-authorship network connecting the top 25 collaborators of S. Spector. A scholar is included among the top collaborators of S. Spector based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Spector. S. Spector is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Wu, Chunjing, S. Spector, George Theodoropoulos, et al.. (2023). Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer. SHILAP Revista de lepidopterología. 11(1). 7–7. 30 indexed citations

2.

Spector, S., et al.. (2022). Abstract 2325: Targeting kynurenine pathway using novel IDO/TDO dual inhibitor (AT0174) to modulate tumor microenvironment in platinum resistant non-small cell lung cancer cancer: An immunometabolism compliment markers. Cancer Research. 82(12_Supplement). 2325–2325. 1 indexed citations

3.

Wangpaichitr, Medhi, George Theodoropoulos, Chunjing Wu, et al.. (2021). Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration. International Journal of Molecular Sciences. 22(14). 7379–7379. 30 indexed citations

4.

Jue, Joshua S., et al.. (2017). Telemedicine broadening access to care for complex cases. Journal of Surgical Research. 220. 164–170. 38 indexed citations

5.

Bhatia, Shivank, et al.. (2014). Is antibiotic prophylaxis necessary for percutaneous radiofrequency ablation of hepatocellular carcinoma. Journal of Vascular and Interventional Radiology. 25(3). S180–S180.

6.

Feun, Lynn G., Min You, C. Wu, et al.. (2008). Arginine Deprivation as a Targeted Therapy for Cancer. Current Pharmaceutical Design. 14(11). 1049–1057. 184 indexed citations

7.

Ardalan, Bach, S. Spector, Alan S. Livingstone, et al.. (2007). Neoadjuvant, Surgery and Adjuvant Chemotherapy without Radiation for Esophageal Cancer. Japanese Journal of Clinical Oncology. 37(8). 590–596. 13 indexed citations

8.

Feun, Lynn G., Niramol Savaraj, C. Wu, et al.. (2006). Phase II study of pegylated arginine deiminase (ADI-PEG20), a novel targeted therapy for melanoma. Journal of Clinical Oncology. 24(18_suppl). 8045–8045. 6 indexed citations

9.

Spector, S., et al.. (2004). Intraoperative lymphatic mapping and sentinel lymph node identification with lymphazurin in patients with resectable esophageal cancer. Annals of Surgical Oncology. 11(S2). S127–S128. 1 indexed citations

10.

Ardalan, Bach, et al.. (2004). Phase II neoadjuvant and adjuvant chemotherapy for localized esophageal carcinoma. Journal of Clinical Oncology. 22(14_suppl). 4147–4147. 1 indexed citations

11.

Millman, Arthur L., et al.. (1987). Steroids and orbital blowout fractures--a new systematic concept in medical management and surgical decision-making.. PubMed. 6. 291–300. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact